Miami, FL, December 12, 2022 – Global Stem Cells Group (GSCG) is pleased to announce the opening of a new Stem Cell Center in Bandung, Indonesia in partnership with the Dr. Yanti Aesthetic Clinic. This joint venture will be the second in the country as they already have another facility in the stunning City of

MIAMI, Florida, October 28, 2022 – The International Society for Stem Cell Application (ISSCA) is excited to announce a regenerative medicine conference in Pakistan. This event will occur on June 10th, 2023, at the University of Lahore ISSCA is a global brand and a top leader in Regenerative Medicine worldwide. This society has partnered with

Miami, FL, October 28, 2022 – Global Stem Cells Group announces a new partnership that enhances its goal of establishing its therapies and technology to meet market demand in populated areas of the world. This collaboration with STEM LIFE clinic’s new facility and Dr. Vanessa Rodriguez Pares, currently one of the most prestigious aesthetic clinics in Mexico

Global Stem Cells Group has just announced the official opening of a new multi-specialty regenerative medicine center in Cancun. The new center is intended to incorporate different treatments based on regenerative medicine as well as to serve as a multi-specialty training center in the field of regenerative medicine and cellular therapies, offering doctors and patients

Global Stem Cells Group (GSCG) has announced the appointment of Dr Rafael Moguel as the new Chief Medical Officer (CMO) of Cellular Hope Institute Cancun. Dr. Moguel, Fellow of the Society for Cardiac Angiography and Intervention (SCAI),  Member of the Mexican Society for Interventional Cardiologists, and Member of the Latin American Society for Interventional Cardiology,

The International Society for Stem Cell Application (ISSCA) is pleased to announce one of the most exciting conferences of the year – the Regenerative Medicine Conference. The conference will take place at the Plaza Hotel-Kirkuk Iraq, on November 11, 2022. About the Regenerative Medicine Conference 2022 The goal of the conference is to encourage more

The International Society of Stem Cell Applications (ISSCA) held its first World Congress on Regenerative Medicine at the Radisson Blu Hotel in Istanbul, Turkey between the 23rd and 26th of September, 2022. Like the previous events, the Congress brought together world-class physicians and scientists from over 35 countries, giving medical professionals access to first-rate live

Recently, the Global Stem Cells Group announced plans to teach physicians the value and process behind incorporating regenerative medicine into their own clinical practices. MIAMI, 4–5 November 2022—Global Stem Cells Group, a multidisciplinary community of scientists and physicians that are working together to cure diseases and relieve human pain through the advancement of the field

Global Stem Cells Group (GSCG) has announced a new on-site training course to be conducted through the International Society for Stem Cell Application (ISSCA) in Ohio. This on-site training course will be presented as a total solution to teach and train medical practitioners on the most recent advances in cellular-based treatments and regenerative medicine. It

The International Society for Stem Cell Application (ISSCA) announced that it would conduct a regenerative medicine certification training course in stem cell therapy in Cancun, Mexico, from 7th to 8th October. Now, the ISSCA is thrilled to announce that the original training course has been sold out. Those still interested in taking this stem cell

The Global Stem Cells Group has announced the launch of a new bone marrow harvesting kit in response to a request for effective and accessible solutions to regenerative medicine procedures  Bone marrow is a spongy tissue that is located inside most large bones – it is essential for generating red blood cells (erythrocytes), white blood

The FDA brought the lawsuit against Cell Surgical Network Clinic in 2018 in an attempt to assert regulatory authority over stem cell therapies. The agency argued that a physician’s use of his patient’s own stem cells as part of the medical treatment provided to the patient was equivalent to manufacturing a biological drug product and